TechnologyPatent OppositionCompetitive Analysis

In the competitive field of Hormone Peptides, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Hormone Peptides technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Hormone Peptides

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Industry Landscape Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Last updated on: Jul 31, 2025
CompanyTotal Oppositions
BEIERSDORF1
EVER VALINJECT1
FERRING1

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Jul 31, 2025
CompanyTotal Oppositions
ACERUS PHARMACEUTICALS USA1
ALLERGAN1
FERRING1
LIPIDOR1
SERENITY PHARMACEUTICALS1

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Last updated on: Jul 31, 2025
CompanyTotal Oppositions Filed
PRINS1
SONN PATENTANWALTE1
UEXKULL & STOLBERG1

Patent challenges are becoming increasingly common in the Hormone Peptides industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Hormone Peptides industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Hormone Peptides industry

Pharmaceutical CompositionFERRINGAug 1, 2022EVER VALINJECT
Sprayable Topical Carrier And Composition Comprising PhosphatidylcholineLIPIDORMar 19, 2020BEIERSDORF
Safe Desmopressin AdministrationALLERGANMar 12, 2018FERRING

To stay ahead in the competitive Hormone Peptides industry, companies are constantly innovating. Here are the top patents facing oppositions in the Hormone Peptides industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Feb 12, 2025Safe Desmopressin AdministrationALLERGAN1
Jul 6, 2022Sprayable Topical Carrier And Composition Comprising PhosphatidylcholineLIPIDOR1
Nov 3, 2021Pharmaceutical CompositionFERRING1